Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C and alcohol

E R Schiff1

  • 1Division of Hepatology, Center for Liver Diseases, University of Miami School of Medicine, FL 33136, USA.

Hepatology (Baltimore, Md.)
|September 26, 1997
PubMed
Summary
This summary is machine-generated.

Chronic alcoholism worsens hepatitis C, accelerating liver disease and increasing cancer risk. Limiting alcohol to under 10g daily is advised, with abstinence recommended for severe cases or during interferon therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.

Human genetics·2018
Same author

Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.

Journal of viral hepatitis·2015
Same author

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin.

Journal of viral hepatitis·2013
Same author

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C.

Alimentary pharmacology & therapeutics·2010
Same author

Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome.

Transplantation proceedings·2008
Same journal

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.

Hepatology (Baltimore, Md.)·2026
Same journal

AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation.

Hepatology (Baltimore, Md.)·2026
Same journal

H4K12 lactylation drives TREM2high macrophages differentiation in liver fibrosis.

Hepatology (Baltimore, Md.)·2026
Same journal

Good vibrations: Using VCTE to predict hepatic decompensation in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

One size does not fit all: Global variability in noninvasive testing for MASLD.

Hepatology (Baltimore, Md.)·2026
See all related articles

Area of Science:

  • Hepatology
  • Viral Hepatitis
  • Alcohol-Related Liver Disease

Background:

  • Chronic alcoholism exacerbates chronic hepatitis C progression.
  • Co-infection accelerates liver disease, leading to cirrhosis and hepatocellular carcinoma.
  • Injection drug use is a primary hepatitis C risk factor in alcoholics, but other transmission routes exist.

Framework:

  • Alcohol intake over 10g/day correlates with increased hepatitis C viral RNA and aminotransferase levels.
  • Mechanisms linking alcohol consumption to viral load and liver enzyme elevation are unclear.
  • Histological findings in co-infected patients are similar to non-alcoholic hepatitis C patients.

Implementation:

  • Interferon therapy shows reduced efficacy in alcoholic patients, even post-abstinence.

Related Experiment Videos

  • Patients with chronic hepatitis C should limit alcohol to <10g/day.
  • Alcohol abstinence is strongly encouraged for patients with cirrhosis or undergoing interferon treatment.

    • Implications:

    • Further research needed on the epidemiology and pathogenesis of combined chronic hepatitis C and alcoholism.
    • Understanding these interactions is crucial for effective patient management and treatment strategies.
    • Public health initiatives may need to address both viral hepatitis and alcohol abuse concurrently.